United States Food and Drug Administration
Research News and Information

Sunday, November 22, 2009

Asenapine.

30 Oct 2009 In August 2009, asenapine (Saphris; Schering-Plough) was approved by the US FDA for the acute treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in ... Read more...

Phakic intraocular lens implantation for the correction of myopia: a report by the American Academy of Ophthalmology.

30 Oct 2009 OBJECTIVE: To review the published literature for evaluation of the safety and outcomes of phakic intraocular lens (pIOL) implantation for the correction of myopia and myopic astigmatism. METHODS: Literature searches of the PubMed and Cochrane ... Read more...

When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective.

30 Oct 2009 To optimize drug therapy for individuals, it is critical to understand how various intrinsic (e.g., age, gender, race, genetics, organ impairment) and extrinsic factors (e.g., diet, smoking, concomitantly administered drugs) affect drug exposure and ... Read more...

Latest indexed articles for 'United States Food and Drug Administration'

These are the very latest articles for this heading:

• Asenapine. 30 Oct 2009
• Twenty five years of poison center experience with propoxyphene overdoses the FDA could not find. 30 Oct 2009
• Devices and drugs for stroke: why do regulations differ? 30 Oct 2009
• Phakic intraocular lens implantation for the correction of myopia: a report by the American Academy of Ophthalmology. 30 Oct 2009
• Expanding treatment options for cocaine dependence. 30 Oct 2009
• When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective. 30 Oct 2009
• How a US regulator can encourage new science. 30 Oct 2009
• FDA steps up efforts to find, remove violators of clinical trial regulations. 26 Oct 2009
• Going off-label without venturing off-course: evidence and ethical off-label prescribing. 24 Oct 2009
• A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment. 21 Oct 2009
• Medical devices; clinical chemistry and clinical toxicology devices; classification of the cardiac allograft gene expression profiling test systems. 19 Oct 2009
• Lost in transmission--FDA drug information that never reaches clinicians. 19 Oct 2009
• Despite health claims by manufacturers, little oversight for homeopathic products. 19 Oct 2009
• Degarelix (firmagon) for prostate cancer. 17 Oct 2009
• Generic drugs revisited. 17 Oct 2009
• Four H1N1 vaccines demonstrate safety and effectiveness, receive FDA approval. 13 Oct 2009
• Capsule endoscopy to screen for colon cancer scores low on sensitivity, high on controversy. 12 Oct 2009
• Radiation overdose in 200 patients leads to FDA safety notice. 11 Oct 2009
• Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes. 10 Oct 2009
• Can the Food and Drug Administration ensure that our pharmaceuticals are safely manufactured? 10 Oct 2009

See a longer list of these articles.

Technical information about 'United States Food and Drug Administration'

Definition: An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.

Descriptor UI: D014486

Alternative terms: United States Food and Drug Administration; USFDA; United States Food, Drug Administration; Food and Drug Administration; Food and Drug Administration (U.S.);

Allowable Qualifiers: classification; economics; history; legislation & jurisprudence; organization & administration; standards; trends; utilization; statistics & numerical data; ethics;

Tree Number: I01.409.137.500.600.650.760; N03.540.348.500.500.600.650.760;

History Note: 66(64)

Technical Notes: add UNITED STATES (NIM); research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; DF: FDA CATALOG: use NAF entry